Cargando…
PRMT5-mediated regulatory arginine methylation of RIPK3
The TNF receptor-interacting protein kinases (RIPK)-1 and 3 are regulators of extrinsic cell death response pathways, where RIPK1 makes the cell survival or death decisions by associating with distinct complexes mediating survival signaling, caspase activation or RIPK3-dependent necroptotic cell dea...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852244/ https://www.ncbi.nlm.nih.gov/pubmed/36658119 http://dx.doi.org/10.1038/s41420-023-01299-z |
_version_ | 1784872573383737344 |
---|---|
author | Chauhan, Chanchal Martinez-Val, Ana Niedenthal, Rainer Olsen, Jesper Velgaard Kotlyarov, Alexey Bekker-Jensen, Simon Gaestel, Matthias Menon, Manoj B. |
author_facet | Chauhan, Chanchal Martinez-Val, Ana Niedenthal, Rainer Olsen, Jesper Velgaard Kotlyarov, Alexey Bekker-Jensen, Simon Gaestel, Matthias Menon, Manoj B. |
author_sort | Chauhan, Chanchal |
collection | PubMed |
description | The TNF receptor-interacting protein kinases (RIPK)-1 and 3 are regulators of extrinsic cell death response pathways, where RIPK1 makes the cell survival or death decisions by associating with distinct complexes mediating survival signaling, caspase activation or RIPK3-dependent necroptotic cell death in a context-dependent manner. Using a mass spectrometry-based screen to find new components of the ripoptosome/necrosome, we discovered the protein-arginine methyltransferase (PRMT)-5 as a direct interaction partner of RIPK1. Interestingly, RIPK3 but not RIPK1 was then found to be a target of PRMT5-mediated symmetric arginine dimethylation. A conserved arginine residue in RIPK3 (R486 in human, R415 in mouse) was identified as the evolutionarily conserved target for PRMT5-mediated symmetric dimethylation and the mutations R486A and R486K in human RIPK3 almost completely abrogated its methylation. Rescue experiments using these non-methylatable mutants of RIPK3 demonstrated PRMT5-mediated RIPK3 methylation to act as an efficient mechanism of RIPK3-mediated feedback control on RIPK1 activity and function. Therefore, this study reveals PRMT5-mediated RIPK3 methylation as a novel modulator of RIPK1-dependent signaling. |
format | Online Article Text |
id | pubmed-9852244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-98522442023-01-21 PRMT5-mediated regulatory arginine methylation of RIPK3 Chauhan, Chanchal Martinez-Val, Ana Niedenthal, Rainer Olsen, Jesper Velgaard Kotlyarov, Alexey Bekker-Jensen, Simon Gaestel, Matthias Menon, Manoj B. Cell Death Discov Article The TNF receptor-interacting protein kinases (RIPK)-1 and 3 are regulators of extrinsic cell death response pathways, where RIPK1 makes the cell survival or death decisions by associating with distinct complexes mediating survival signaling, caspase activation or RIPK3-dependent necroptotic cell death in a context-dependent manner. Using a mass spectrometry-based screen to find new components of the ripoptosome/necrosome, we discovered the protein-arginine methyltransferase (PRMT)-5 as a direct interaction partner of RIPK1. Interestingly, RIPK3 but not RIPK1 was then found to be a target of PRMT5-mediated symmetric arginine dimethylation. A conserved arginine residue in RIPK3 (R486 in human, R415 in mouse) was identified as the evolutionarily conserved target for PRMT5-mediated symmetric dimethylation and the mutations R486A and R486K in human RIPK3 almost completely abrogated its methylation. Rescue experiments using these non-methylatable mutants of RIPK3 demonstrated PRMT5-mediated RIPK3 methylation to act as an efficient mechanism of RIPK3-mediated feedback control on RIPK1 activity and function. Therefore, this study reveals PRMT5-mediated RIPK3 methylation as a novel modulator of RIPK1-dependent signaling. Nature Publishing Group UK 2023-01-19 /pmc/articles/PMC9852244/ /pubmed/36658119 http://dx.doi.org/10.1038/s41420-023-01299-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Chauhan, Chanchal Martinez-Val, Ana Niedenthal, Rainer Olsen, Jesper Velgaard Kotlyarov, Alexey Bekker-Jensen, Simon Gaestel, Matthias Menon, Manoj B. PRMT5-mediated regulatory arginine methylation of RIPK3 |
title | PRMT5-mediated regulatory arginine methylation of RIPK3 |
title_full | PRMT5-mediated regulatory arginine methylation of RIPK3 |
title_fullStr | PRMT5-mediated regulatory arginine methylation of RIPK3 |
title_full_unstemmed | PRMT5-mediated regulatory arginine methylation of RIPK3 |
title_short | PRMT5-mediated regulatory arginine methylation of RIPK3 |
title_sort | prmt5-mediated regulatory arginine methylation of ripk3 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852244/ https://www.ncbi.nlm.nih.gov/pubmed/36658119 http://dx.doi.org/10.1038/s41420-023-01299-z |
work_keys_str_mv | AT chauhanchanchal prmt5mediatedregulatoryargininemethylationofripk3 AT martinezvalana prmt5mediatedregulatoryargininemethylationofripk3 AT niedenthalrainer prmt5mediatedregulatoryargininemethylationofripk3 AT olsenjespervelgaard prmt5mediatedregulatoryargininemethylationofripk3 AT kotlyarovalexey prmt5mediatedregulatoryargininemethylationofripk3 AT bekkerjensensimon prmt5mediatedregulatoryargininemethylationofripk3 AT gaestelmatthias prmt5mediatedregulatoryargininemethylationofripk3 AT menonmanojb prmt5mediatedregulatoryargininemethylationofripk3 |